Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by rabiion Jan 25, 2010 7:59pm
1277 Views
Post# 16717471

NICK DEMARE INSIDER SELLER

NICK DEMARE INSIDER SELLERthis guy is a terrible shareholder....any chance he gets to make a buck he sells....

Halo Resources Ltd. (HLO)

As of January 24th, 2010
Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction # or value acquired or disposed of Unit Price
Jan 24/10 Jan 19/10 DeMare, Nick Control or Direction Common Shares 10 - Disposition in the public market -61,105
.095
Jan 24/10 Jan 18/10 DeMare, Nick Control or Direction Common Shares 10 - Disposition in the public market -65,000
.095
Jan 23/10 Jan 22/10 DeMare, Nick Indirect Ownership Common Shares 10 - Disposition in the public market -60,000
.085
Jan 23/10 Jan 21/10 DeMare, Nick Indirect Ownership Common Shares 10 - Disposition in the public market -40,000
.090
Jan 23/10 Jan 20/10 DeMare, Nick Indirect Ownership Common Shares 10 - Disposition in the public market -50,500
.090
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse